Anti-Estrogen Receptor alpha 抗体 [SP1]
Anti-Estrogen Receptor alpha antibody [SP1]
- BOND RX™ Validated
- RabMAb
- Recombinant
- Lab Essentials
- Advanced Validation
- 20ul selling size
- 了解详情
4
(7 Reviews)
|
(88 Publications)
Anti-Estrogen Receptor alpha antibody [SP1] (ab16660) is a rabbit monoclonal antibody detecting Estrogen Receptor alpha in Western Blot, Flow Cytometry (Intra), Flow Cytometry, IHC-P, ICC/IF, mIHC. Suitable for Human.
- Multiplex IHC validated on the Leica BOND® MAX using Opal reagents
- Biophysical QC for unrivalled batch-batch consistency
- Over 60 publications
- Trusted since 2005
查看别名
ESR, NR3A1, ESR1, Estrogen receptor, ER, ER-alpha, Estradiol receptor, Nuclear receptor subfamily 3 group A member 1
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Estrogen Receptor alpha antibody [SP1] (AB16660)
Formalin-fixed paraffin-embedded human breast ductal carcinoma tissue stained for Estrogen Receptor alpha using ab16660 at 1/200 dilution in immunohistochemical analysis.
This image was generated using the hybridoma version of the product.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-Estrogen Receptor alpha antibody [SP1] (AB16660)
ab16660 staining Estrogen Receptor alpha in MCF7 cells. The cells were fixed with 4% formaldehyde (10min) permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated overnight at +4°C with ab16660 at 1/250 dilution (shown in green) and ab195889 Mouse monoclonal [DM1A] to alpha Tubulin (Alexa Fluor® 594) at 2μg/ml (shown in red). Nuclear DNA was labelled with DAPI (shown in blue).
Image was taken with a confocal microscope (Leica-Microsystems TCS SP8).
This image was generated using the hybridoma version of the product.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Estrogen Receptor alpha antibody [SP1] (AB16660)
Immunocytochemistry/ Immunofluorescence analysis of MCF7 (human breast adenocarcinoma epithelial cell) cells labeling Estrogen Receptor alpha with purified ab16660 at 1/25 dilution (8.5 μg/ml). Cells were fixed in 100% Methanol. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) at 1/200 dilution (2.5 μg/ml). Goat anti rabbit IgG (Alexa Fluor® 488 ab150077) was used as the secondary antibody at 1/1000 (2 μg/ml) dilution. DAPI was used as nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
This image was generated using the hybridoma version of the product.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Estrogen Receptor alpha antibody [SP1] (AB16660)
Intracellular flow cytometry analysis of MCF7 (human breast adenocarcinoma epithelial cell) labeling Estrogen Receptor alpha with purified ab16660 at 1/200 dilution (1.06 μg/ml) (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Goat anti rabbit IgG (Alexa Fluor® 488 ab150077) at 1/2000 dilution was used as a secondary antibody. Isotype control - Rabbit monoclonal IgG (ab172730) (black). Unlableled control - Unlabelled cells (blue).This image was generated using the hybridoma version of the product.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Estrogen Receptor alpha antibody [SP1] (AB16660)
Formalin-fixed paraffin-embedded human ovarian adenocarcinoma tissue stained for Estrogen Receptor alpha using ab16660 at 1/200 dilution in immunohistochemical analysis.
This image was generated using the hybridoma version of the product.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Estrogen Receptor alpha antibody [SP1] (AB16660)
Human breast carcinoma stained with ab16660.
This image was generated using the hybridoma version of the product.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Estrogen Receptor alpha antibody [SP1] (AB16660)
IHC image of ab16660 staining Estrogen Receptor alpha in normal human cervix formalin-fixed paraffin-embedded tissue sections* performed on a Leica Bond. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6 epitope retrieval solution 1) for 20 mins. The section was then incubated with ab16660 1/250 dilution for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. No primary antibody was used in the negative control (shown on the inset).
This image was generated using the hybridoma version of the product.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions primary antibody concentration and antibody incubation times.
*Tissue obtained from the Human Research Tissue Bank supported by the NIHR Cambridge Biomedical Research Centre
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Estrogen Receptor alpha antibody [SP1] (AB16660)
Formalin-fixed paraffin-embedded human breast carcinoma tissue stained for Estrogen Receptor alpha using ab16660 at 1/200 dilution in immunohistochemical analysis.
This image was generated using the hybridoma version of the product.
- mIHC
Supplier Data
Multiplex immunohistochemistry - Anti-Estrogen Receptor alpha antibody [SP1] (AB16660)
Multiplex immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human mammary gland tissue sections labeling Estrogen Receptor (ER) with ab16660, at a 1/200 dilution ( 0.07 μg/ml). Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins and Opal Polymer HRP Ms + Rb was used as the secondary antibody. DAPI was used as the nuclear counterstain. Panel A : merged staining of anti-Progesterone Receptor (PR) (magenta; Opal™690), anti-HER2 (red; Opal™570) and anti-Estrogen Receptor (ER) (green; Opal™520) on human mammary gland. Panel B : anti-PR stained on nucleus of some ductal cells. Panel C : anti-HER2 stained on no cells. Panel D : anti-ER stained on nucleus of some ductal cells. The section was incubated in three rounds of staining : in the order of ab16661 for 30 mins, then ab16660 and ab231438 for 10 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system. The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Estrogen Receptor alpha antibody [SP1] (AB16660)
Formalin-fixed paraffin-embedded human breast tissue stained for Estrogen Receptor alpha using ab16660 at 1/200 dilution in immunohistochemical analysis.
This image was generated using the hybridoma version of the product.
- mIHC
Supplier Data
Multiplex immunohistochemistry - Anti-Estrogen Receptor alpha antibody [SP1] (AB16660)
Multiplex immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human triple-negative breast carcinoma tissue sections labeling Estrogen Receptor (ER) with ab16660, at a 1/200 dilution ( 0.07 μg/ml). Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins and Opal Polymer HRP Ms + Rb was used as the secondary antibody. DAPI was used as the nuclear counterstain. Panel A : merged staining of anti-Progesterone Receptor (PR) (magenta; Opal™690), anti-HER2 (red; Opal™570) and anti-Estrogen Receptor (ER) (green; Opal™520) on human triple-negative breast carcinoma. Panel B : anti-PR stained on no cells. Panel C : anti-HER2 stained on no cells. Panel D : anti-ER stained on no cells. The section was incubated in three rounds of staining : in the order of ab16661 for 30 mins, then ab16660 and ab231438 for 10 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system. The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.
- mIHC
Supplier Data
Multiplex immunohistochemistry - Anti-Estrogen Receptor alpha antibody [SP1] (AB16660)
Multiplex immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human triple-positive breast carcinoma tissue sections labeling Estrogen Receptor (ER) with ab16660, at a 1/200 dilution ( 0.07 μg/ml). Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins and Opal Polymer HRP Ms + Rb was used as the secondary antibody. DAPI was used as the nuclear counterstain. Panel A : merged staining of anti-Progesterone Receptor (PR) (magenta; Opal™690), anti-HER2 (red; Opal™570) and anti-Estrogen Receptor (ER) (green; Opal™520) on human triple-positive breast carcinoma. Panel B : anti-PR stained on nucleus of cancer cells. Panel C : anti-HER2 stained on membrane of cancer cells. Panel D : anti-ER stained on nucleus of cancer cells. The section was incubated in three rounds of staining : in the order of ab16661 for 30 mins, then ab16660 and ab231438 for 10 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system. The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.
- WB
Lab
Western blot - Anti-Estrogen Receptor alpha antibody [SP1] (AB16660)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The expression profile/molecular weight observed is consistent with what has been described in the literature (PMID : 16165085, PMID : 31036290). The identity of the lower MW band below 37kDa is unknown.
All lanes:
Western blot - Anti-Estrogen Receptor alpha antibody [SP1] (ab16660) at 1/1000 dilution
All lanes:
T-47D (human mammary gland ductal carcinoma epithelial cell) whole cell lysates at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 46-66 kDa
false
Exposure time: 180s
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Estrogen Receptor alpha antibody [SP1] (AB16660)
Tissue Microarrays stained for Anti-Estrogen Receptor alpha antibody [SP1] using ab16660 in immunohistochemical analysis. This table provides a detailed overview of positive (tick mark) and negaive (cross mark) staining per sample type tested. The section was incubated with ab16660 for 10 mins at room temperature followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Heat mediated antigen retrieval was performed with Citrate buffer (pH 6.0, Epitope Retrieval Solution 1) for 10 mins.
- WB
CiteAb
Western blot - Anti-Estrogen Receptor alpha antibody [SP1] (AB16660)
Estrogen Receptor alpha western blot using anti-Estrogen Receptor alpha antibody [SP1] ab16660. Publication image and figure legend from Kangaspeska, S., Hultsch, S., et al., 2016, BMC Cancer, PubMed 27378269.
ab16660 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab16660 please see the product overview.
Tamoxifen-resistant cells develop common drug sensitivities and co-resistances. a Venn diagrams illustrate shared drug sensitivities and co-resistances of drugs with a DSS difference of at least 5. b Rank-product analysis of Drug Sensitivity Scores (DSS) between tamoxifen-resistant and parental cell lines identified statistically significant shared sensitizing and desensitizing drugs. c Western blot of EGFR, pEGFR, ERK1/2, pERK1/2, ERα and βactin under increasing concentrations of VX-11E and 1 μM selumetinib of T-47D and BT-474 isogenic cell lines. Resistant cell lines were cultured in media supplemented with 1 μM tamoxifen
false
反应性数据
产品详情
Anti-Estrogen Receptor alpha antibody [SP1] (ab16660) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IHC-P, WB, mIHC in human samples.
Anti-Estrogen Receptor alpha antibody [SP1] (ab16660) has been cited over 62 times in peer reviewed journals and is trusted by the scientific community.
Abcams high quality manufacturing and validation processes ensure Anti-Estrogen Receptor alpha antibody [SP1] (ab16660) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
Anti-Estrogen Receptor alpha antibody [SP1] (ab16660) has 7 independent reviews from customers.
Anti-Estrogen Receptor alpha antibody [SP1] (ab16660) specifically detects Estrogen Receptor alpha (UniProt ID: P03372; Molecular weight: 66kDa) and is sold in 100 uL, 500 uL and 1 mL selling sizes.
Conjugation-ready, carrier free format available for antibody clone SP1 - ab18726.
Antibody clone SP1 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 647, Alexa Fluor® 555, Alexa Fluor® 594, PE, APC, HRP, Alkaline Phosphatase, Alexa Fluor® 568, Alexa Fluor® 75 (ab267512, ab282199, ab282651, ab35384, ab35385, ab35386, ab38794, ab312515, ab321152).
Anti-Estrogen Receptor alpha antibody [SP1] (ab16660) is a clone from the portfolio of Spring Bioscience (Roche) SP clones which have been optimised for immunohistochemistry (IHC).
Estrogen Receptor alpha (ERα), also known as ESR1, is a nuclear hormone receptor that binds estrogens and is expressed in about 70% of breast cancers. It plays a critical role in tumor development and progression by promoting cell division and growth when activated by estrogen.
This product has switched from a hybridoma to recombinant production format on 21st May 2020.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Estrogen Receptor alpha functions as part of a large transcriptional complex. Upon binding estrogen it undergoes a conformational change that allows interaction with other transcriptional regulators like ER SP1. This interaction facilitates the recruitment of coactivators or corepressors influencing the transcription of target genes involved in proliferation differentiation and cell survival. It is critical in mediating estrogen signaling pathways that contribute to normal development and function of female reproductive organs as well as cardiovascular and skeletal systems.
Pathways
Estrogen Receptor alpha engages in estrogen signaling and PI3K/AKT pathways. In estrogen signaling ER alpha interacts with proteins such as AP1 enhancing transcriptional activity related to cell growth and survival. Within the PI3K/AKT pathway ER alpha coordinates with proteins like SRC promoting cell proliferation and survival. Its actions in these pathways impact a wide variety of cellular processes influencing tissue homeostasis and growth regulation.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (88)
Recent publications for all applications. Explore the full list and refine your search
Molecular cancer therapeutics : PubMed40931856
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of ovarian research 18:151 PubMed40652270
2025
Applications
Unspecified application
Species
Unspecified reactive species
Discover oncology 16:814 PubMed40388071
2025
Applications
Unspecified application
Species
Unspecified reactive species
Bioactive materials 46:582-596 PubMed40061435
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 16:57 PubMed39890799
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature 638:1130-1138 PubMed39779860
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature cardiovascular research 4:45-63 PubMed39747454
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell international 24:433 PubMed39731167
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 15:1481972 PubMed39582864
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in endocrinology 15:1440654 PubMed39512757
2024
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com